new england journal of medicine aspirin | Aspirin or Low-Molecular-Wei

Keyword	CPC	PCC	Volume	Score	Length of keyword
new england journal of medicine aspirin	1.07	0.1	6673	6	39
new	0.83	0.7	153	82	3
england	1.69	0.8	2060	41	7
journal	1.87	0.1	9780	91	7
of	1.72	0.2	968	96	2
medicine	1.39	0.7	2368	90	8
aspirin	1.92	0.4	3550	44	7

Keyword	CPC	PCC	Volume	Score
new england journal of medicine aspirin	1.19	0.6	899	59
new england journal of medicine aspirin study	0.61	0.5	5550	43
new study on low dose aspirin	1.37	0.6	6390	56
latest news about aspirin	1.66	0.6	558	18
latest news on low dose aspirin	0.93	0.5	5771	47
latest news on taking aspirin	1.72	0.9	7225	59
surprising news about aspirin	1.42	0.2	9832	62
news about aspirin today	1.27	1	5988	58
brief introduction of aspirin	1.99	0.9	3011	30
aspirin every day new study	1.16	0.7	2635	42
long term current use of aspirin	0.22	0.4	9209	1
low dose aspirin news	1.12	0.4	7443	69
new warning about daily aspirin	1	0.2	8146	19
new guidelines for aspirin use	0.8	1	9140	59
nejm aspirin primary prevention	0.68	0.1	8834	87
prolonged use of aspirin	0.34	0.1	2128	42
nhs low dose aspirin	0.95	0.4	946	70
expected pharmacological action aspirin	0.41	0.6	9436	49
latest news on aspirin a day	0.76	1	7245	36
aspirin 80 mg drug study	1.47	0.5	1908	91
low dose aspirin study	1.32	0.4	4589	7
low dose coated aspirin	1.38	0.8	4703	57
american heart association aspirin	1.42	0.8	487	40
aspirin in the uk	1.59	0.2	1996	38

Search Results related to new england journal of medicine aspirin on Search Engine

Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis …
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa2205973

WebJan 18, 2023 · N Engl J Med 2023;388: 203 - 213. DOI: 10.1056/NEJMoa2205973. VOL. 388 NO. 3. Abstract. Background. Clinical guidelines recommend low-molecular-weight heparin for thromboprophylaxis in...

DA: 69 PA: 86 MOZ Rank: 90

Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | New …
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa1803955

WebSep 16, 2018 · In the primary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial, now published in the Journal, we report that the daily use of aspirin did not provide a benefit with...

DA: 86 PA: 93 MOZ Rank: 29

Comparative Effectiveness of Aspirin Dosing in Cardiovascular …
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa2102137

WebMay 15, 2021 · N Engl J Med 2021;384: 1981 - 1990. DOI: 10.1056/NEJMoa2102137. VOL. 384 NO. 21. Abstract. Background. The appropriate dose of aspirin to lower the risk of death, myocardial infarction,...

DA: 8 PA: 23 MOZ Rank: 100

Comparative Effectiveness of Aspirin Dosing in Cardiovascular …
nih.gov

https://pubmed.ncbi.nlm.nih.gov/33999548/

WebMay 27, 2021 · Methods: Using an open-label, pragmatic design, we randomly assigned patients with established atherosclerotic cardiovascular disease to a strategy of 81 mg or 325 mg of aspirin per day. The primary effectiveness outcome was a composite of death from any cause, hospitalization for myocardial infarction, or hospitalization for stroke, assessed ...

DA: 23 PA: 25 MOZ Rank: 64

Comparative Effectiveness of Aspirin Dosing in Cardiovascular …
bmc2.org

https://www.bmc2.org/sites/default/files/2021-08/nejmoa2102137.pdf

Web(Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness), an open-label, pragmatic, randomized, controlled trial, to assess whether a strategy of aspirin at a dose of 325 mg per day would result in a lower risk of death from any cause, hospitalization for myo-cardial infarction, or hospitalization for stroke

DA: 60 PA: 72 MOZ Rank: 75

Clinical effectiveness and safety of aspirin and other …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880907/

WebDec 12, 2022 · Clinical effectiveness and safety of aspirin and other anticoagulants for venous thromboembolism prophylaxis after major orthopedic surgery: a systematic review and meta-analysis of randomized clinical trials - PMC. Journal List. EFORT Open Rev. v.7 (12); 2022 Dec 1. PMC9880907. As a library, NLM provides access to scientific literature.

DA: 10 PA: 57 MOZ Rank: 4

Effect of Aspirin on Cardiovascular Events and Bleeding in the …
nih.gov

https://pubmed.ncbi.nlm.nih.gov/30221597/

WebOct 18, 2018 · PMID: 30221597. PMCID: PMC6289056. DOI: 10.1056/NEJMoa1805819. Abstract. Background: Aspirin is a well-established therapy for the secondary prevention of cardiovascular events. However, its role in the primary prevention of cardiovascular disease is unclear, especially in older persons, who have an increased risk.

DA: 95 PA: 37 MOZ Rank: 70

Of Aspirin, Preeclampsia, and Racism | New England Journal of Medicine
org.tw:30443

https://www-nejm-org.lib3.cgmh.org.tw:30443/doi/full/10.1056/NEJMp2311019

WebMar 9, 2024 · Of Aspirin, Preeclampsia, and Racism | New England Journal of Medicine. Perspective. Of Aspirin, Preeclampsia, and Racism. Authors: David A.Sacks, M.D. https://orcid.org/0000-0003-3444-6476, and Marc H.Incerpi, M.D. Author Info & Affiliations. Published March 9, 2024. N Engl J Med 2024;390: 968 - 969. DOI: 10.1056/NEJMp2311019. VOL. NO. Notes.

DA: 2 PA: 99 MOZ Rank: 61

Aspirin Trial Concludes with Dose Recommendations
dukehealth.org

https://physicians.dukehealth.org/articles/aspirin-trial-concludes-dose-recommendations

WebNov 9, 2021 · Published in the New England Journal of Medicine (NEJM) in May, the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness trial (ADAPTABLE) trial answers a question asked by clinicians and patients for years, says W. Schuyler Jones, MD, a Duke cardiologist, principal investigator of the study, and lead author of ...

DA: 20 PA: 11 MOZ Rank: 93

What Happened to Aspirin? And What Replaces It? - Medscape
medscape.com

https://www.medscape.com/viewarticle/saga-aspirin-preventing-heart-disease-2024a10007za

Web15 hours ago · A landmark study published in 1988 in the New England Journal of Medicine reported an astonishing 44% drop in the number of heart attacks among US male physicians aged 40-84 years who took aspirin.

DA: 49 PA: 5 MOZ Rank: 19